American Scientific Resources to Present at Friedland Investment Events' Winter Life Sciences Conference
Posted on: Wednesday, 31 October 2007, 09:01 CDT
Dr. Christopher F. Tirotta, CEO and Chairman of the Board of American Scientific Resources, Inc. (PINKSHEETS: ASFX), will present at Friedland Investment Events' Winter Life Sciences Conference on Thursday, November 1, 2007 in New York, NY at the DoubleTree Guest Suites Times Square. American Scientific Resources, Inc. is the holding company for wholly owned subsidiaries Kidz-Med, Inc. and Heart Smart System, Inc.
Dr. Tirotta will discuss the Company's growth plans for its Kidz-Med subsidiary, introduce Kidz-Med's flagship product, the Kidz-Med Thermofocus(R) 5-in-1, the world's first non-contact clinical thermometer, and discuss the launch of the Company's Heart Smart product line scheduled for 2008.
"I am very much looking forward to participating in the Life Sciences Conference, and educating the attendees on the promising developments of late," stated Dr. Tirotta. "With the exciting news of Thermofocus' new distribution through a major brick and mortar retailer, we continue to validate our Company as a strong investment opportunity," Dr. Tirotta concluded.
The Kidz-Med Thermofocus(R) 5-in-1 Non-Contact clinical thermometer uses completely safe, advanced infrared technology and patented aiming lights to take instantaneous temporal (forehead) temperature readings, which are deemed as accurate as rectal and ear thermometer readings, without ever actually touching the skin. Thermofocus is used and recommended by doctors and pediatricians throughout the US, UK and Europe. Kidz-Med is the exclusive retail distributor of the Thermofocus in the U.S.
Friedland Investment Events is the world's largest sponsor of financial and investment events. Friedland Undervalued Equities conferences bring together CEOs and other chief executives from publicly traded and privately held micro-cap companies from a range of industries, including life sciences, technology, energy, and mining.
About American Scientific Resources, Inc. (http://www.americansci.com)
American Scientific Resources, Inc. (PINKSHEETS: ASFX) is a leader in providing innovative next-generation, health, medical and safety products through its wholly owned subsidiaries Kidz-Med, Inc. and Heart Smart System, Inc. Products are distributed primarily through Walgreens, nationwide healthcare suppliers, major retail online sites and the subsidiary websites (www.kidzmed.com and www.heartsmartsystem.com). Kidz-Med distributes a leading line of unique safety and health-related pediatric products, including the Kidz-Med Thermofocus(R) 5-in-1, the world's first non-contact clinical thermometer. Heart Smart supplies a superior line of nutraceutical supplements developed to aid in the prevention of cardiovascular disease, utilizing the most bio-available form of CoQ10, Hydro-Qsorb(R) contained within the flagship product Heart Smart Foundation Supplement. Additional information about American Scientific may be found at www.americansci.com. Investor data may be obtained at www.StockBroadcasting.com/featured/ASFX/.
Statements in this press release that are not statements of historical or current fact constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of the Company to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes,""belief,""expects,""intends,""anticipates,""will," or "plans" to be uncertain and forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company's reports and registration statements filed with the Securities and Exchange Commission.
Contacts: ROI Group LLC John Tsemberides 212-495-0743 john@roiny.com I.R. International Consultants, Inc. Sandy Rossen 516-816-2563 trexben@aol.com
SOURCE: American Scientific
Source: MARKET WIRE
Related Articles
- Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions
- NovaBay Pharmaceuticals' Scientific Advisor Receives American Chemical Society's Highest Award
- Cytokinetics Announces Clinical Trials Data Relating to CK-1827452 Presented at the 12th Annual Scientific Meeting of the Japanese Heart Failure Society
- Statement From Bayer(R) Aspirin Regarding the American Medical Association's New Aspirin Policy Resolution
- American Academy of Dermatology Issues Statement Urging the Public to Be Sun Smart(SM)
- Kidz-Med to Launch the Thermofocus(R) 5-in-1 Exclusively at Walgreens Stores Nationwide
- Statement From Larry Minnix, President & CEO, American Association of Homes and Services for the Aging (AAHSA), on the Introduction of the CLASS Act
- Abbott Statement on FIELD Study Presented at American Heart Association Meeting and Published in The Lancet
- Heart Failure Society of America's 9th Annual Scientific Meeting Features Progress in Heart Failure Research and Patient Care
- UK Astronomers Look Forward to Looking Back
User Comments (0)

RSS Feeds